VELSIPITY is a once-daily, oral, sphingosine 1-phosphate (S1P) receptor modulator that selectively binds with S1P receptor subtypes 1, 4, and 5. KIRKLAND, QC – Pfizer Canada announced that Health Canada… Read More
The first living recipient of a UThymoKidney, in conjunction with a heart pump implant, is recovering after a successful transplant This transplant builds on two successful UHeart transplants completed in… Read More
For over a decade, Moderna has been at the intersection of science, technology and health. Since our beginnings, we’ve leveraged the power of machine learning to support our mission to… Read More
Provides enhanced microbial resolution We are thrilled to introduce our long-read sequencing services to help deliver an enhanced understanding of the microbiome and its functional implications to our clients.” —… Read More
KIRKLAND, QC & HAMILTON, ON – During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing critical gaps in health… Read More
